Skip to main content

Tweets

VEXAS may be more common than expected A great study of a recently described rheumatologic/hematologic disorder VEXAS syndrome recently appeared in JAMA, describing the frequency and presentations of UBA1 variant. https://t.co/OFaeH62eHy https://t.co/7znps74Llv
Dr. John Cush @RheumNow ( View Tweet )
3 years 5 months ago
Blood Test Identifies Osteoarthritis Progression A new blood test that can identify progression of osteoarthritis in the knee is more accurate than current methods, providing an important tool to advance research and speed discovery of new therapies. https://t.co/hOAjxJhnJG https://t.co/Ehr5imPNQ4
Dr. John Cush @RheumNow ( View Tweet )
3 years 5 months ago
A Shortage of Trust I’ve oft heard the truism that “Trust is in short supply”. This is so true. Those I value most, are the ones I trust the most. My nurse practitioner, my front desk gal, my medical partner, and my best friend... https://t.co/AXIDAJQUta https://t.co/GJwQq04dUC
Dr. John Cush @RheumNow ( View Tweet )
3 years 5 months ago
Join us on 3/18 and 3/19 in Dallas, Texas or virtually for RheumNow Live! Who is coming? https://t.co/LLUufQDhHv https://t.co/nKTN5KBtuc
Dr. John Cush @RheumNow ( View Tweet )
3 years 5 months ago
Variable Pregnancy Outcomes with Belimumab in SLE An analysis looked at outcomes in pregnant SLE exposed to belimumab reported there are few pregnancies and confounding disease and comorbidity factors to provide clear guidance for such patients. https://t.co/pkyAcE0aNr https://t.co/MB4AGmtSdp
Dr. John Cush @RheumNow ( View Tweet )
3 years 5 months ago
702 #SLE pts (age 29 yrs) from India, measured plasma 25-hydroxyvitamin-D(25(OH)D) - median levels were 22.83 (13.8–31.8) ng/ml. Low Vit D(< 20) seen in 41.5%; correlated w/ age/geography, & weak neg correlation w/ weak negative correlation w/ SLEDAI2K https://t.co/EUPqJGKAhI https://t.co/MEIL5yd64n
Dr. John Cush @RheumNow ( View Tweet )
3 years 5 months ago
Early Ph IIa study of ATI-450 (Zunsemetinib), an investigational selective MAP kinase–2 (MK2) blocker leds to a sustained antiinflammatory effect; studied in 19 RA pts w/ ACR 20/50/70 of 60%/33%/20% at wk 12. https://t.co/IyjJCgdXG2

Dr. John Cush @RheumNow ( View Tweet )

3 years 5 months ago
"Dry Synovitis" exist in juvenile arthritis pts? Study of 12 DS pts, says its different from Poly #JIA; onset 6.1 yrs, w/ polyarthritis, no palpable swelling, progressive LOM/contractures, neg ESR/CRP/RF/CCP, +MRI synovitis w/ osteochondral involvement.https://t.co/tL2G7QKBL4 https://t.co/k4QoAmTGYA
Dr. John Cush @RheumNow ( View Tweet )
3 years 5 months ago
Have a Rheumatology question or case for Jack Cush? Record it here and we may feature it on an upcoming podcast. Tell us your name and where you practice rheumatology. https://t.co/RaFKTqhQjN https://t.co/hH0NcpOoyx
Dr. John Cush @RheumNow ( View Tweet )
3 years 5 months ago
Why not end your patient visit with a recitation pledging your service and commitment: "Your coming to see me to day is very important, to the both of us. I pledge to be of service to you. Together WE can certainly improve your health" https://t.co/9U95LoiDQi https://t.co/dMWunEXjWk
Dr. John Cush @RheumNow ( View Tweet )
3 years 5 months ago
Recent NEJM has reviewed arthroplasty-associated infection and PJI, noting this is a rare event; notably these infections are caused by skin microorganisms introduced during arthroplasty surgery or may be seeded post-surgically. https://t.co/DXflkGnsdK https://t.co/GgfeSSl4xJ
Dr. John Cush @RheumNow ( View Tweet )
3 years 5 months ago
JAK-pot Study: To Cycle or Switch after JAK inhibitor Failure? Data from 17 international registries suggest that for RA patients failing their first JAKi, it did not matter if they were cycled to another JAKi or switched to a bDMARD. https://t.co/xLZveIoaRG https://t.co/tBpJUgOqaN
Dr. John Cush @RheumNow ( View Tweet )
3 years 5 months ago
×